Plasma and Cerebrospinal Fluid Pharmacokinetics of Intravenous Temozolomide in Non-human Primates

Mahendra Patel, Cynthia McCully(National Cancer Institute), Karen Godwin(National Cancer Institute), Frank M. Balis(National Cancer Institute)

Journal of Neuro-Oncology

February 1, 2003

10.1023/a:1022592913323

Cited by 148

Abstract

Related Papers

Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

W.K. Alfred Yung, Michael D. Prados, Ricardo Yayá et al.|Journal of Clinical Oncology|1999|761

Temozolomide and treatment of malignant glioma.

Henry S. Friedman, Tracy Kerby, Hilary Calvert|PubMed|2000|725

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

ES Newlands, GRP Blackledge, J. Slack et al.|British Journal of Cancer|1992|488

Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.

M. F. G. STEVENS, J A Hickman, S P Langdon et al.|PubMed|1987|390

Mlab — A mathematical modeling tool

Gary D. Knott|Computer Programs in Biomedicine|1979|380